Annual report
4323.TEDINET S100YI5H
Period2025-04-01 → 2026-03-31
Filed2026-06-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amended by S100YOCW (2026-07-03).
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥32.5bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥29.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥26.2bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥23.5bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥21.4bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥3.9bn | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥3.2bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥4.0bn | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.3bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.9bn | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.5bn | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.1bn | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.7bn | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.3bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.6bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.4bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.1bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.8bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.3bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2.6bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥2.5bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥25.3bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥22.9bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥20.0bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥17.4bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥15.5bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥8.5bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥8.1bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥16.8bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥14.8bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥12.7bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥10.8bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥9.2bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥9.1bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥7.1bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.8bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.7bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.5bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥6.5bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥3.0bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.9bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.1bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.2bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥53m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥761m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥542m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥81m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥1.0bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥599m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥424m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥281m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥487m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥106.07 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥99.24 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.08 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥72.25 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥56.16 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥677.71 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥596.97 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥516.08 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥439.03 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥373.43 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 66.2% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.4% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.2% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.8% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.9% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 16.6% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.8% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.8% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.8% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 16.7% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,683 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 1,613 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 1,847 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 1,687 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 1,448 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥27.4bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥24.2bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥20.4bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥18.6bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥17.1bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥3.9bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥3.0bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥4.1bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥3.4bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.2bn | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.1bn | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.8bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥4.1bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥3.4bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥3.2bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥2.7bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥1.6bn | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.6bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥1000m | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥23.0bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥20.4bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥17.3bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥15.5bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥14.0bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥7.2bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥6.8bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥15.9bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥13.7bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥11.4bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥10.2bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥8.8bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥7.0bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥5.1bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥128.62 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥109.22 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥65.82 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥66.47 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥42.19 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥45 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥27 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥45 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥32 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥641.61 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥552.55 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥466.42 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥415.93 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥358.96 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 68.8% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.9% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.9% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.8% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.0% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 21.5% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 21.4% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.9% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.2% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.7% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 24,836,920 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 24,836,920 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,418,460 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,418,460 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,209,230 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,202 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 1,151 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 1,009 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 926 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 871 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 68
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2026-03-31 | −¥94m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2026-03-31 | −¥94m |
| Reconciling Itemsreconciling | segment assets | at 2026-03-31 | ¥3.1bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2026-03-31 | −¥2.1bn |
| Global Businessreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥25m |
| Global Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥85m |
| Global Businessreportable segment | employees | at 2026-03-31 | 299 pure |
| Global Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥2.3bn |
| Global Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥2.3bn |
| Global Businessreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥78m |
| Global Businessreportable segment | segment assets | at 2026-03-31 | ¥1.9bn |
| Global Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | −¥401m |
| Medical Big Data Businessreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥18m |
| Medical Big Data Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥40m |
| Medical Big Data Businessreportable segment | employees | at 2026-03-31 | 175 pure |
| Medical Big Data Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥3.5bn |
| Medical Big Data Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥3.5bn |
| Medical Big Data Businessreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥6m |
| Medical Big Data Businessreportable segment | segment assets | at 2026-03-31 | ¥3.3bn |
| Medical Big Data Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥887m |
| Package Businessreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥26m |
| Package Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥49m |
| Package Businessreportable segment | employees | at 2026-03-31 | 269 pure |
| Package Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥6.9bn |
| Package Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥6.9bn |
| Package Businessreportable segment | segment assets | at 2026-03-31 | ¥6.3bn |
| Package Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2025-04-01 → 2026-03-31 | ¥129m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2025-04-01 → 2026-03-31 | ¥310m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2026-03-31 | ¥32.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2026-03-31 | ¥32.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥94m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2026-03-31 | ¥22.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2026-03-31 | ¥6.0bn |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥114m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥114m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥3.3bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥1.8bn |
| Global Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥93m |
| Global Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥76m |
| Global Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥2.8bn |
| Global Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥2.8bn |
| Global Businessreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥79m |
| Global Businessreportable segment | segment assets | at 2025-03-31 | ¥2.4bn |
| Global Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | −¥62m |
| Medical Big Data Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥49m |
| Medical Big Data Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥33m |
| Medical Big Data Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥3.2bn |
| Medical Big Data Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥3.2bn |
| Medical Big Data Businessreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥556,000 |
| Medical Big Data Businessreportable segment | segment assets | at 2025-03-31 | ¥2.8bn |
| Medical Big Data Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥662m |
| Package Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥53m |
| Package Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥37m |
| Package Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥5.9bn |
| Package Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥5.9bn |
| Package Businessreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥4m |
| Package Businessreportable segment | segment assets | at 2025-03-31 | ¥4.7bn |
| Package Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.6bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥329m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥237m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥29.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥29.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥114m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥19.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥5.0bn |
| Medical Big Data Businessreportable segment | employees | at 2026-03-31 | 116 pure |
| Package Businessreportable segment | employees | at 2026-03-31 | 264 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,662
| Item | Context | Value | Unit |
|---|---|---|---|
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | 4.891 | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 4.949 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 5.499 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | 0.996 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 1.025 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 1.417 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.361 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 1.790 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row1Member | 20 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row1Member | 14.7 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row2Member | 80 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row2Member | 87.5 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row3Member | 85 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row3Member | 86.1 | |
| Research and development expenses research and development activities | CurrentYearDuration | 588978000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E05236-000DXAndSIBusinessMember | 105226000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E05236-000PackageBusinessReportableSegmentMember | 365076000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E05236-000MedicalBigDataBusinessReportableSegmentMember | 118675000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 129027000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E05236-000DXAndSIBusinessMember | 60308000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E05236-000PackageBusinessReportableSegmentMember | 25958000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E05236-000MedicalBigDataBusinessReportableSegmentMember | 17974000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E05236-000GlobalBusinessReportableSegmentMember | 24775000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 24836920 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 24836920 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 24836920 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 24836920 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 8 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 15 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 19 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 58 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 13 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 2858 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 2971 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 23405 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 1228 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 61359 | |
| Number of shares held number of units foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 83821 | |
| Number of shares held number of units foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 60 | |
| Number of shares held number of units individuals and others | CurrentYearInstant_OrdinaryShareMember | 78420 | |
| Number of shares held number of units total | CurrentYearInstant_OrdinaryShareMember | 248293 | |
| Number of shares held shares less than one unit | CurrentYearInstant_OrdinaryShareMember | 7620 | |
| Percentage of shareholdings national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Percentage of shareholdings financial institutions | CurrentYearInstant_OrdinaryShareMember | 0.0942 | |
| Percentage of shareholdings financial service providers | CurrentYearInstant_OrdinaryShareMember | 0.0049 | |
| Percentage of shareholdings other corporations | CurrentYearInstant_OrdinaryShareMember | 0.2471 | |
| Percentage of shareholdings foreigners other than individuals | CurrentYearInstant_OrdinaryShareMember | 0.3375 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |